EUVIMEDEUVIMED entdecken
Crossref

Loss-of-function SLC25A20 variant causes carnitine-acylcarnitine translocase deficiency by reducing SLC25A20 protein stability

Zhongzhi Gan, Xiaofeng Wei, Yingchun Zheng, Qiqi Zheng, Shushu Fan, Fu Xiong

Gene · 2025

DOI: 10.1016/j.gene.2024.149201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene, 2025. Verfasst von Zhongzhi Gan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics/Experimental Education/Administration Center, School of Basic Medical Sciences, Southern Medical University, Guangzhou…. Hauptthemen laut MEDLINE: Carnitine Acyltransferases, Mitochondrial Membrane Transport Proteins, Loss of Function Mutation, Lipid Metabolism, Inborn Errors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Autosomal-recessive carnitine-acylcarnitine translocase deficiency (CACTD) is a rare disorder of long-chain fatty acid oxidation caused by variants in the SLC25A20 gene, leading to energy deficiency and the toxic accumulation of long-chain acylcarnitines. Under fasting conditions, most newborns with severe CACTD experience sudden cardiac arrest and hypotonia, often leading to premature death due to rapid disease progression. The genetic factors and pathogenic mechanisms in CACTD are essential for its diagnosis, treatment, and prevention. METHODS: Whole-exome sequencing was carried out on the CACTD patients. Bioinformatics analysis predicted the pathogenicity and three-dimensional structure of SLC25A20. Quantitative PCR was employed to detect changes in SLC25A20, CPT1A and CPT2 mRNA levels. The expression and stability of the variant protein were assessed via Western blot. Additionally, the subcellular localization of the variant protein was observed using immunofluorescence. RESULTS: We identified compound heterozygous pathogenic variants of SLC25A20 (c.476 T > C and c.199-10 T > G) in CACTD families, with patients exhibiting an abnormal carnitine spectrum. In vitro functional studies demonstrated that the c.476 T > C and c.199-10 T > G variants decreased the protein stability of SLC25A20, reduced CPT1A and CPT2 mRNA expression, and caused protein aggregation of SLC25A20. CONCLUSIONS: We propose that the decreased stability of the SLC25A20 variants c.476 T > C and c.199-10 T > G has the potential to lead to the development of CACTD by affecting the mitochondrial shuttle of acylcarnitine and carnitine, thereby inhibiting the β-oxidation pathway. Therefore, we believe these compound heterozygous variants (c.199-10 T > G and c.476 T > C) are loss-of-function variants. Our findings provide valuable data on CACTD pathogenesis and genotype-phenotype correlations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carnitine AcyltransferasesMitochondrial Membrane Transport ProteinsLoss of Function MutationLipid Metabolism, Inborn ErrorsMuscular DiseasesMetabolism, Inborn ErrorsHumansMaleFemaleExome SequencingProtein StabilityCarnitine O-PalmitoyltransferasePedigreeCarnitineInfant, NewbornMembrane Transport Proteins

Stichwörter der Autor:innen

CACTDCompound heterozygous variantsLoss-of-functionProtein stabilitySLC25A20c.199-10T>G and c.476T>C variants

Substanzen

Carnitine AcyltransferasesSLC25A20 protein, humanCarnitine O-PalmitoyltransferaseMitochondrial Membrane Transport ProteinsCarnitineMembrane Transport Proteins

Autor:innen und Institutionen

  • Department of Medical Genetics/Experimental Education/Administration Center, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Prenatal Diagnosis Center, Yuebei People's Hospital, Shao Guan 512000 Guandong, China. Electronic address: shaoguanfss@aliyun.com.
  • Department of Medical Genetics/Experimental Education/Administration Center, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Single Cell Tec…

Zitieren

APA

Gan, Z., Wei, X., Zheng, Y., Zheng, Q., Fan, S., & Xiong, F. (2025). Loss-of-function SLC25A20 variant causes carnitine-acylcarnitine translocase deficiency by reducing SLC25A20 protein stability. Gene. https://doi.org/10.1016/j.gene.2024.149201

Vancouver

Gan Z, Wei X, Zheng Y, Zheng Q, Fan S, Xiong F. Loss-of-function SLC25A20 variant causes carnitine-acylcarnitine translocase deficiency by reducing SLC25A20 protein stability. Gene. 2025. doi:10.1016/j.gene.2024.149201

BibTeX
@article{Gan2025,
  author = {Gan, Zhongzhi and Wei, Xiaofeng and Zheng, Yingchun and Zheng, Qiqi and Fan, Shushu and Xiong, Fu},
  title = {Loss-of-function SLC25A20 variant causes carnitine-acylcarnitine translocase deficiency by reducing SLC25A20 protein stability},
  journal = {Gene},
  year = {2025},
  doi = {10.1016/j.gene.2024.149201}
}
Kostenlos starten →